The fans now have the chance to meet eight-time Ballon d'Or winner Lionel Messi and even click a photo with him. Lionel Messi is gearing up for a highly anticipated visit to India as part of his GOAT ...

Two Texas men plotted to invade a Haitian island with the goal of murdering all the men and using the women and children as sex slaves, federal prosecutors said in a news release. Gavin Rivers ...

Fresh off The White Stripes' induction into the Rock & Roll Hall of Fame, a new box set will celebrate the "Seven Nation Army" duo's discography. The package will be available in limited quantities at ...

The Federal Reserve cut interest rates this past week by a quarter of a percentage point. But where rates go from here is a coin toss, at best, given that Fed members’ latest forecasts diverge widely.

Days after Inc42 reported Kiwi securing INR 208.5 Cr (around $24 Mn) in its Series B funding round led by Vertex Ventures, the startup has now confirmed the development. In a statement, the startup ...

Interior designer extraordinaire MaCenna Lee offers five fresh macrame wall hanging ideas that are quick, stylish, and beginner-friendly. State Department begins widespread layoffs, cutting 1,353 ...

The David Corenswet-led superhero pic opens around the globe later this week. By Carly Thomas Associate Editor With James Gunn‘s highly anticipated Superman set to launch his and Peter Safran’s new DC ...

This article is republished with permission from Wonder Tools, a newsletter that helps you discover the most useful sites and apps. Subscribe here. AI-generated voices are increasingly hard to ...

Decision-making in sales and marketing is accelerating. Whether it’s a salesperson deciding their next move, a manager reshuffling customer assignments, or a leadership team shaping strategy, fast, ...

Differential cardiotoxicity of acalabrutinib versus chemoimmunotherapy in chronic lymphocytic leukemia: A retrospective cohort study from 2000-2025 using TriNetX database. This is an ASCO Meeting ...

Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...